Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00805506 · ClinicalTrials.gov registry record
Evaluation of Glucose Monitoring Methods: Characterizing Glycemic Control in Subjects With Diabetes
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 16
- Enrollment target
NCT00805506: Completed study, sponsored by HealthPartners Institute.
NCT00805506 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00805506 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
Evaluate the usefulness of continuous glucose monitoring devices in terms of their ability to identify periods throughout the day when glucose varies significantly.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-04 |
What the finished NCT00805506 record still lists
NCT00805506 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00805506 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00805506 about?
NCT00805506 is a clinical study titled "Evaluation of Glucose Monitoring Methods: Characterizing Glycemic Control in Subjects With Diabetes". Evaluate the usefulness of continuous glucose monitoring devices in terms of their ability to identify periods throughout the day when glucose varies significantly.
What is the current status of trial NCT00805506?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2006-02. Estimated completion is 2007-04.
Who is sponsoring clinical trial NCT00805506?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia